Cargando…

Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease

OBJECTIVE: To recognize risk factors and build up and validate a simple risk model predicting 8‐year cancer events after nonalcoholic fatty liver disease (NAFLD). METHODS: This was a retrospective cohort study. Patients with NAFLD (n = 5561) were randomly divided into groups: training (n = 1254), te...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Zihan, Ren, Zhigang, Hu, Shuang, Gao, Yan, Sun, Ranran, Lv, Shuai, Yang, Guojie, Yu, Zujiang, Kan, Quancheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997093/
https://www.ncbi.nlm.nih.gov/pubmed/31860170
http://dx.doi.org/10.1002/cam4.2777
_version_ 1783493620882472960
author Wei, Zihan
Ren, Zhigang
Hu, Shuang
Gao, Yan
Sun, Ranran
Lv, Shuai
Yang, Guojie
Yu, Zujiang
Kan, Quancheng
author_facet Wei, Zihan
Ren, Zhigang
Hu, Shuang
Gao, Yan
Sun, Ranran
Lv, Shuai
Yang, Guojie
Yu, Zujiang
Kan, Quancheng
author_sort Wei, Zihan
collection PubMed
description OBJECTIVE: To recognize risk factors and build up and validate a simple risk model predicting 8‐year cancer events after nonalcoholic fatty liver disease (NAFLD). METHODS: This was a retrospective cohort study. Patients with NAFLD (n = 5561) were randomly divided into groups: training (n = 1254), test (n = 627), evaluation (n = 627), and validation (n = 3053). Risk factors were recognized by statistical method named as a Cox model with Markov chain Monte Carlo (MCMC) simulation. This prediction score was established based on the training group and was further validated based on the testing and evaluation group from January 1, 2007 to December 31, 2009 and another 3053 independent cases from January 1, 2010 to February 13, 2014. RESULTS: The main outcomes were NAFLD‐related cancer events, including those of the liver, breast, esophagus, stomach, pancreas, prostate and colon, within 8 years after hospitalization for NAFLD diagnosis. Seven risk factors (age (every 5 years),LDL, smoking, BMI, diabetes, OSAS, and aspartate aminotransferase (every 5 units)) were identified as independent indicators of cancer events. This risk model contained a predictive range of 0.4%‐37.7%, 0.3%‐39.6%, and 0.4%‐39.3% in the training, test, evaluation group, respectively, with a range 0.4%‐30.4% for validation groups. In the training group, 12.6%, 76.9%, and 10.5% of patients, which corresponded to the low ‐, moderate ‐, and high‐risk groups, had probabilities of, <0.01, <0.1, and 0.23 for 8‐year events. CONCLUSIONS: Seven risk factors were recognized and a simple risk model were developed and validated to predict the risk of cancer events after NAFLD based on 8 years. This simple risk score system may recognize high‐risk patients and reduce cancer incidence.
format Online
Article
Text
id pubmed-6997093
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69970932020-02-05 Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease Wei, Zihan Ren, Zhigang Hu, Shuang Gao, Yan Sun, Ranran Lv, Shuai Yang, Guojie Yu, Zujiang Kan, Quancheng Cancer Med Cancer Prevention OBJECTIVE: To recognize risk factors and build up and validate a simple risk model predicting 8‐year cancer events after nonalcoholic fatty liver disease (NAFLD). METHODS: This was a retrospective cohort study. Patients with NAFLD (n = 5561) were randomly divided into groups: training (n = 1254), test (n = 627), evaluation (n = 627), and validation (n = 3053). Risk factors were recognized by statistical method named as a Cox model with Markov chain Monte Carlo (MCMC) simulation. This prediction score was established based on the training group and was further validated based on the testing and evaluation group from January 1, 2007 to December 31, 2009 and another 3053 independent cases from January 1, 2010 to February 13, 2014. RESULTS: The main outcomes were NAFLD‐related cancer events, including those of the liver, breast, esophagus, stomach, pancreas, prostate and colon, within 8 years after hospitalization for NAFLD diagnosis. Seven risk factors (age (every 5 years),LDL, smoking, BMI, diabetes, OSAS, and aspartate aminotransferase (every 5 units)) were identified as independent indicators of cancer events. This risk model contained a predictive range of 0.4%‐37.7%, 0.3%‐39.6%, and 0.4%‐39.3% in the training, test, evaluation group, respectively, with a range 0.4%‐30.4% for validation groups. In the training group, 12.6%, 76.9%, and 10.5% of patients, which corresponded to the low ‐, moderate ‐, and high‐risk groups, had probabilities of, <0.01, <0.1, and 0.23 for 8‐year events. CONCLUSIONS: Seven risk factors were recognized and a simple risk model were developed and validated to predict the risk of cancer events after NAFLD based on 8 years. This simple risk score system may recognize high‐risk patients and reduce cancer incidence. John Wiley and Sons Inc. 2019-12-20 /pmc/articles/PMC6997093/ /pubmed/31860170 http://dx.doi.org/10.1002/cam4.2777 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Prevention
Wei, Zihan
Ren, Zhigang
Hu, Shuang
Gao, Yan
Sun, Ranran
Lv, Shuai
Yang, Guojie
Yu, Zujiang
Kan, Quancheng
Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease
title Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease
title_full Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease
title_fullStr Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease
title_full_unstemmed Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease
title_short Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease
title_sort development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease
topic Cancer Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997093/
https://www.ncbi.nlm.nih.gov/pubmed/31860170
http://dx.doi.org/10.1002/cam4.2777
work_keys_str_mv AT weizihan developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease
AT renzhigang developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease
AT hushuang developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease
AT gaoyan developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease
AT sunranran developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease
AT lvshuai developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease
AT yangguojie developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease
AT yuzujiang developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease
AT kanquancheng developmentandvalidationofasimpleriskmodeltopredictmajorcancersforpatientswithnonalcoholicfattyliverdisease